Search results for: Gynesonics

Need a new search

If you didn't find what you were looking for, try a new search!

Interview with Chris Owens, CEO & President at Gynesonics, Inc

What is Gynesonics about? How are you changing the standard of care in uterine fibroids? Gynesonics is focused on advancing women’s health by developing uterus-preserving, incision free, transcervical technology. Currently, we are focused on the treatment of symptomatic uterine fibroids, a [...]

2023-04-12T13:51:29+01:00May 24th, 2019|

Gynesonics announces $75 million financing

Redwood City, CA – January 3, 2019 – Gynesonics, a women’s healthcare company and the developer of the Sonata System and other advanced, incision-free solutions for the treatment of uterine conditions, today announced that it has completed a $75 million equity [...]

2023-05-04T15:04:15+01:00January 3rd, 2019|

Gynesonics receives FDA clearance to market Sonata System

Advanced technology offers potential to become a new standard of care for fibroid treatment Redwood City, CA – August 22, 2018 – Gynesonics, a women’s healthcare company focused on the development of minimally-invasive solutions for symptomatic uterine fibroids, today announced that [...]

2023-05-08T09:12:38+01:00August 22nd, 2018|

Gynesonics Announces Submission of FDA 510k for Incision-Free Treatment of Symptomatic Uterine Fibroids

Novel uterus-preserving Sonata System is first incision-free treatment to address majority of fibroids transcervically REDWOOD CITY, Calif.–(BUSINESS WIRE)–Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for uterine fibroids, today announced its submission to the FDA of [...]

2023-04-12T13:32:32+01:00December 21st, 2017|
Go to Top